AUS
NZ
UK
CA
USA
IND
Cannabis
ASX Cannabis Stocks: Why Product Quality And Cash Flow Now Matter More Than Hype
June 08, 2026 12:16 PM AEST| By SamASX cannabis stocks in 2026 focus on product quality, patient access, cash discipline, and operational transparency, with ECS Botanics, Vitura Health, Althea, and Bod Science providing measurable evidence.
Telix Trial Update Puts Theranostics Back in Focus
June 05, 2026 02:57 PM AEST| By SamTelix reported encouraging ProstACT safety data and expanded an imaging partnership, reinforcing attention on radiopharmaceuticals, theranostics and oncology innovation across Australia’s healthcare market.
Could This Be the Turning Point for ASX Cannabis Stocks?
June 05, 2026 02:52 PM AEST| By SamASX cannabis stocks are attracting fresh attention as investors focus on operational delivery, regulatory developments and export opportunities, with companies increasingly judged on business fundamentals, financial discipline and long-term commercia...
What’s Really Stirring Interest in ASX Cannabis Stocks?
June 05, 2026 02:50 PM AEST| By SamASX cannabis stocks remain a closely watched sector as medicinal demand, export opportunities, regulation and company execution shape market sentiment. Operational progress and financial discipline are increasingly driving attention across the catego...
ASX Cannabis Stocks Stir Fresh Debate as Sector Signals Shift
June 05, 2026 02:48 PM AEST| By SamASX cannabis stocks are regaining attention as markets focus on operational delivery, earnings quality and sector catalysts. Companies across the industry highlight how business execution and evolving market conditions continue shaping the narrative.
Can ASX Cannabis Exposure Survive the Hype Cycle?
June 04, 2026 01:19 PM AEST| By SamA disciplined ASX cannabis guide covering revenue quality, certified production, cash runway, regulation, liquidity, and small-cap portfolio structure.
Why Is ASX 300 Medicinal Cannabis Gaining Momentum?
June 04, 2026 01:18 PM AEST| By SamAustralia's medicinal cannabis industry has evolved into a regulated healthcare sector supported by cultivation, manufacturing, patient access, clinical research, and export activity.
US Cannabis Reform and ASX 300: ASX Pot Stock Sector Guide
June 04, 2026 01:18 PM AEST| By SamUS cannabis rescheduling may reshape sector sentiment, research access and export discussions for ASX cannabis names linked to medical and clinical pathways.
ASX Cannabis Leaders Within ASX 200 Focus
June 03, 2026 11:31 AM AEST| By SamExplore the ASX cannabis value chain, from cultivation and manufacturing to exports and therapeutic development, and understand how cannabis businesses differ across the healthcare sector.
Could ASX Cannabis Stocks Be Entering a New Market Phase?
June 03, 2026 11:31 AM AEST| By SamASX cannabis stocks remain linked to medicinal healthcare, regulation, manufacturing, and commercial expansion, making the sector a distinctive part of Australia's evolving healthcare landscape.
Cannabis Stocks on ASX 200: What’s Driving Attention?
June 03, 2026 11:29 AM AEST| By SamAustralia's medicinal cannabis industry continues expanding through patient access, healthcare adoption, manufacturing development, and export activity, with several ASX-listed companies shaping the sector.
Cannabis Stocks Across ASX 300 Gain Industry Attention
June 02, 2026 12:14 PM AEST| By SamAustralia's medicinal cannabis sector has evolved into a structured healthcare industry supported by patient access, manufacturing capability, distribution networks, and specialised product development.
Why Are ASX Cannabis Stocks Drawing Fresh Attention?
June 02, 2026 12:14 PM AEST| By SamExplore ASX cannabis stocks including Althea Group Holdings, Cann Group, Little Green Pharma, Incannex Healthcare, and Bod Science across healthcare and wellness markets.
Cannabis Stocks in All Ordinaries Market Spotlight
June 02, 2026 12:14 PM AEST| By SamAustralia's medicinal cannabis industry continues to evolve through healthcare innovation, regulation, manufacturing capability, patient access expansion, and international market participation.
Why Are Cannabis Stocks Drawing Global Market Interest?
June 01, 2026 10:45 AM AEST| By SamCannabis-focused companies remain a notable part of Australia's healthcare sector, with medicinal cannabis, pharmaceutical research, cultivation, and wellness products shaping industry activity in 2026.
Why Are Cannabis Stocks Back on the ASX 300 Radar?
June 01, 2026 10:44 AM AEST| By SamASX medicinal cannabis stocks remain in focus as patient access, regulation, product quality, exports, and healthcare distribution shape the sector in 2026.
Leading Cannabis Stocks Across ASX 200 Healthcare Focus
June 01, 2026 10:42 AM AEST| By SamExplore ASX cannabis stocks including Althea Group Holdings, Cann Group, Creso Pharma, Little Green Pharma, Bod Science, MGC Pharmaceuticals, and EcoFibre as medicinal cannabis continues evolving within Australia's healthcare sector.
Healthcare Innovators Across ASX 300 Remain in Focus
May 29, 2026 01:32 PM AEST| By SamEmerging healthcare companies continue participating in therapeutic research, healthcare technology development and patient-focused service activities across evolving healthcare markets.
Why Are ASX 300 Cannabis Healthcare Stocks Gaining Attention?
May 29, 2026 01:28 PM AEST| By SamIncannex Healthcare (ASX:IHL), Emyria (ASX:EMD) and Bod Science (ASX:BOD) represent specialised cannabis-healthcare businesses spanning therapeutic research, healthcare services and consumer wellness products.
ASX 300 Medicinal Cannabis Market Expands
May 29, 2026 01:25 PM AEST| By SamASX cannabis stocks LGP, CAN, and AGH highlight cultivation, production, and distribution within a regulated medicinal market shaped by healthcare adoption and evolving policies.
Advertise your brand on Kalkine Media